Raymond James Financial Services Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.1M | Buy |
|
|||||
|
2024
Q2 | $3.98M | Sell |
|
|||||
|
2024
Q1 | $4.11M | Sell |
|
|||||
|
2023
Q4 | $4.39M | Buy |
|
|||||
|
2023
Q3 | $2.79M | Sell |
|
|||||
|
2023
Q2 | $3.31M | Sell |
|
|||||
|
2023
Q1 | $7.93M | Buy |
|
|||||
|
2022
Q4 | $5.85M | Buy |
|
|||||
|
2022
Q3 | $3.85M | Buy |
|
|||||
|
2022
Q2 | $1.66M | Sell |
|
|||||
|
2022
Q1 | $1.97M | Sell |
|
|||||
|
2021
Q4 | $1.61M | Sell |
|
|||||
|
2021
Q3 | $1.27M | Hold |
|
|||||
|
2021
Q2 | $1.37M | Buy |
|
|||||
|
2021
Q1 | $1.09M | Buy |
|
|||||
|
2020
Q4 | $791K | Sell |
|
|||||
|
2020
Q3 | $704K | Sell |
|
|||||
|
2020
Q2 | $1.13M | Buy |
|
|||||
|
2020
Q1 | $912K | Hold |
|
|||||
|
2019
Q4 | $888K | Hold |
|
|||||
|
2019
Q3 | $1.26M | Sell |
|
|||||
|
2019
Q2 | $912K | Buy |
|
|||||
|
2019
Q1 | $1.21M | Hold |
|
|||||
|
2018
Q4 | $455K | Hold |
|
|||||
|
2018
Q3 | $895K | Hold |
|
|||||
|
2018
Q2 | $739K | Hold |
|
|||||
|
2018
Q1 | $566K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $39K | Hold |
|
|||||
|
2017
Q2 | $43K | Hold |
|
|||||
|
2017
Q1 | $30K | Hold |
|
|||||
|
2016
Q4 | $16K | Hold |
|
|||||
|
2016
Q3 | $17K | Hold |
|
|||||
|
2016
Q2 | $11K | Buy |
|
|||||
|
2016
Q1 | $16K | Buy |
|